Gastrointestinal Cancer Pooled Safety Analysis of Trifluridine/Tipiracil in Metastatic Cancer - Phase III Mar 14, 2023
Gastrointestinal Cancer STELLAR-303 Study: XL092 and Atezolizumab vs. Regorafenib in mCRC Mar 14, 2023
Gastrointestinal Cancer Tislelizumab Outperforms Chemotherapy in 1L Advanced GC/GEJC: Phase 3 Study Mar 14, 2023
Bladder Cancer,Genitourinary Cancer CheckMate 274 Trial: Adjuvant Nivolumab vs Placebo in MIUC Analysis Mar 14, 2023
Bladder Cancer,Genitourinary Cancer JAVELIN Bladder 100: Avelumab for Advanced UC in Subgroups Mar 14, 2023
Gastric Cancer,Gastrointestinal Cancer Impact of Skipping Bevacizumab on IMBRAVE150 HCC Treatment Efficacy Mar 14, 2023
Genitourinary Cancer Phase 3 Trial on Lenvatinib Plus Pembrolizumab vs. Sunitinib in Advanced RCC Mar 13, 2023
